Table 2 Number and funding source of papers and individual trials following level 2 exclusion criteria application
Number of cat papers (trials) | Number of dog papers (trials) | Number of horse papers (trials) | Number of cattle papers (trials) | Number of sheep papers (trials) | Total number of papers (trials, % of total trials) | |
|---|---|---|---|---|---|---|
Papers including pharmaceutical agent RCTs | 17 | 49 | 28 | 61 | 17 | 172 |
Papers excluded from analysis | 9 | 21 | 17 | 29 | 10 | 86 |
Papers analysed | 8 (9 trials) | 28 (44 trials) | 11 (11 trials) | 32 (36 trials) | 7 (26 trials) | 86 (126 trials) |
Funding sources of analysed papers | ||||||
Pharmaceutical company funded/pharmaceutical company involvement | 4 (5 trials) | 17 (33 trials) | 4 (4 trials) | 20 (23 trials) | 2 (21 trials) | 47 (86 trials; 68%) |
Non pharmaceutical funding stated | 3 (3 trials) | 4 (4 trials) | 2 (2 trials) | 6 (7 trials) | 3 (3 trials) | 18 (19 trials; 15%) |
No funding stated | 1 (1 trial) | 7 (7 trials) | 5 (5 trials) | 6 (6 trials) | 2 (2 trials) | 21 (21 trials; 17%) |